Stroke and associated comorbidities in Southeast Asian countries
Aishika Datta1, Soumya Akundi1, Kaveri Wagh1
1Department of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad Gandhinagar Gujarat India.
Insights
Stroke is a major global health issue. This review highlights how comorbidities like hypertension and hyperglycemia worsen stroke outcomes, especially in Southeast Asia due to data gaps.
Area of Science:
- Neurology
- Public Health
- Epidemiology
Background:
- Stroke is a leading cause of death and disability globally.
- Diverse risk factors include age, sex, ethnicity, and lifestyle diseases.
- Comorbidities significantly worsen stroke outcomes and increase population burden.
Purpose of the Study:
- To review published studies on stroke comorbidities.
- To emphasize the incidence and prevalence of stroke burden in Southeast Asia.
- To address research disparities linked to insufficient demographic data on comorbidities.
Main Methods:
- Comprehensive review of published hospital-based studies.
- Analysis of data from national stroke registries.
- Focus on Southeast Asian countries and their developing economies.
Main Results:
- High stroke prevalence in Southeast Asia imposes a substantial healthcare and economic burden.
- Insufficient documentation of stroke-related comorbidities complicates management in developing nations.
- Research disparities are often linked to inadequate demographic data on comorbidities.
Conclusions:
- Understanding the association between comorbidities and stroke is crucial for effective management.
- Addressing data gaps in Southeast Asia is vital for improving stroke care and reducing burden.
- Further research is needed to elucidate the full impact of comorbidities on stroke in diverse populations.
Abstract:
Stroke, a leading cause of mortality and morbidity worldwide, is a complex cerebrovascular disease. Stroke risk factors are diverse, encompassing age, sex, and ethnicity. Comorbid conditions, including hypertension, hyperglycemia, hyperlipidemia, and atrial fibrillation, exacerbate stroke outcomes, contributing to the overall stroke burden within populations. In addition to these factors, lifestyle-related diseases can impact individuals across all age groups, and often include as comorbidities linked to stroke. Socioeconomic conditions, healthcare access, and the quality of clinical data significantly influence the prevalence of comorbidities. Asia, the largest continent and home to 60% of the world's population, includes many developing nations undergoing diverse economic transitions. In Southeast Asian countries, stroke prevalence is high, imposing a substantial burden on healthcare systems and economies. Research disparities in stroke are often attributed to insufficient demographic data on comorbidities. Hence, the review discusses all previously published results of hospital-based studies and data from national registries. It has been noticed that due to insufficient documentation on stroke-related comorbidities in various developing countries of Southeast Asia, stroke management becomes difficult. Therefore, this review aims to discuss the association between various comorbidities and stroke, with special emphasis on the incidence and prevalence of stroke burden in Southeast Asian countries.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations


